Status:
COMPLETED
0.6 vs. 1.2 mg Atropine Together With Neostigmine 2.5 mg on Heart Rate in Patient Receiving Muscle Relaxant
Lead Sponsor:
Mahidol University
Conditions:
Bradycardia
Neostigmine Adverse Reaction
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Balanced general anesthesia with neuromuscular blocking agents has been widely used for surgery.. At the end of surgery, neostigmine has been given for the reversal of neuromuscular blocking agents wi...
Eligibility Criteria
Inclusion
- ASA physical status 1-3
- age = or \> 18 years
- patient receiving neuromuscular blocking agent
Exclusion
- baseline heart rate before administration of the study drugs \< 65 bpm
- history of allergy to the study drugs
- patient receiving either of the following drugs include beta-blockers, calcium channel blocker, amiodarone or digoxin
- history of complete heart block or second degree AV block.
Key Trial Info
Start Date :
March 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2013
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT02186132
Start Date
March 1 2012
End Date
February 1 2013
Last Update
July 10 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.